olanzapine and fluoxetine
Generic: olanzapine and fuoxetine
Labeler: endo usa, inc.Drug Facts
Product Profile
Brand Name
olanzapine and fluoxetine
Generic Name
olanzapine and fuoxetine
Labeler
endo usa, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
fluoxetine hydrochloride 25 mg/1, olanzapine 3 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
49884-277
Product ID
49884-277_c2eef390-8690-4148-ac37-45e392be15a6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077742
Listing Expiration
2026-12-31
Marketing Start
2012-11-26
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
49884277
Hyphenated Format
49884-277
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olanzapine and fluoxetine (source: ndc)
Generic Name
olanzapine and fuoxetine (source: ndc)
Application Number
ANDA077742 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 3 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE, PLASTIC (49884-277-11)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c2eef390-8690-4148-ac37-45e392be15a6", "openfda": {"nui": ["N0000175430"], "upc": ["0349884253110", "0349884277116", "0349884250119", "0349884251116", "0349884252113"], "unii": ["N7U69T4SZR", "I9W7N6B1KJ"], "rxcui": ["403969", "403970", "403971", "403972", "721787"], "spl_set_id": ["2f6ceda3-3edc-4427-98a6-23e3c930c44d"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (49884-277-11)", "package_ndc": "49884-277-11", "marketing_start_date": "20121126"}], "brand_name": "Olanzapine and Fluoxetine", "product_id": "49884-277_c2eef390-8690-4148-ac37-45e392be15a6", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]", "Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "49884-277", "generic_name": "olanzapine and fuoxetine", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine and Fluoxetine", "active_ingredients": [{"name": "FLUOXETINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "OLANZAPINE", "strength": "3 mg/1"}], "application_number": "ANDA077742", "marketing_category": "ANDA", "marketing_start_date": "20121126", "listing_expiration_date": "20261231"}